Update on Guidance Notes for Active Pharmaceutical Ingredients (API) Information for Product Registration - Version 6.0 (March 2021)

User Rating: 5 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Active
 

 

Please be informed that there has been an update on the Guidance Notes for Active Pharmaceutical Ingredient (API) Information Required for Product Registration. The updated document is available for download:

 

 

The summary of changes on Guidance Notes for Active Pharmaceutical Ingredient (API) Information Required for Product Registration are outlined below:

 

Version

Description of Updates

Effective date

Version 6.0

Rearrangement of topics title. Topics which are incorporated in updated DRGD (Third edition, Jan 2021) are removed from this Guidance Notes.

 

Addition of Part D: Mode of Submission for Drug Master Files (DMFs)

 

Addition of Part E: Product Registration Application Referencing to WHO Prequalified APIs

 

Updating of Appendix I: Addition of WHO PQ requirements

 

Updating of Appendix IV: Addition of Cetylpyridinium Chloride, Mannitol and Malic Acid as examples of Atypical API

 

Editorial changes:

-   DRGD Appendix 6 changed to DRGD Appendix 11

 

-       Change of label of Appendixes of Guidance Notes from 1, 2, 3, 4 & 5 to I, II, III, IV & V

March 2021

 

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Profesor Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Friday 15 October 2021, 15:58:04.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Main Menu English

Choose Your Language